Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825161 · ClinicalTrials.gov registry record
The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)
A clinical trial, sponsored by AO Foundation, AO Spine.
- Completed
- Registry status
- 454
- Enrollment target
NCT01825161: Completed study, sponsored by AO Foundation, AO Spine.
NCT01825161 is a clinical trial that has completed, run by AO Foundation, AO Spine. The registered enrollment target is 454 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01825161 has completed, sponsored by AO Foundation, AO Spine.
- COMPLETED
- Registry status
- 454 participants
- Enrollment target
Study Summary
The main purpose of this study is to utilize a comprehensive, prospective clinical database to collect patient, diagnostic and treatment variables along with disease specific and generic health related quality of life (HRQOL) data on consecutively treated patients with metastatic spine tumors. The objectives are to determine the validity and reliability of the Spine Cancer Outcomes Questionnaire (SCOQ) for use in the assessment of spine tumor outcomes, to determine if the Spine Instability Neoplastic Score (SINS) Classification is a valid tool for predicting the stability of spine in metastatic spine disease, and to determine the efficacy of surgery versus radiotherapy for the treatment of impending instability secondary to metastatic disease of the spine.
Primary Outcome
This is a new questionnaire, also referred to as the Spine Oncology Self-Assessment, developed by members of the SOSG. It is made up of 5 domains: physical function, neural function, pain, mental health and social function. It was developed as a comparison to the SF-36 for patients with spine tumors. The reliability and validity of this questionnaire will be compared with the SF-36v2.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2013-08 |
| Est. Completion | 2019-12 |
What the finished NCT01825161 record still lists
NCT01825161 is an observational study that tracks outcomes without assigning an intervention. The registered 454 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01825161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01825161 about?
NCT01825161 is a clinical study titled "The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)". The main purpose of this study is to utilize a comprehensive, prospective clinical database to collect patient, diagnostic and treatment variables along with disease specific and generic health related quality of life (HRQOL) data on consecutively treated patients with metastatic spine tumors. The o...
What is the current status of trial NCT01825161?
This trial is currently completed. The enrollment target is 454 participants. The study started on 2013-08. Estimated completion is 2019-12.
Who is sponsoring clinical trial NCT01825161?
This trial is sponsored by AO Foundation, AO Spine, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05489211 · 454 participants · Phase 2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- NCT05655936 · 454 participants · NA
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
- NCT06510374 · 454 participants · Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- NCT06935357 · 454 participants · Phase 3
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia